Navigation Links
Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
Date:8/13/2008

Patients to be Offered Additional Testing Services Provided by Interleukin

Genetics

WALTHAM, Mass., and BRENTWOOD, Tenn., Aug. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), and OralDNA Labs, Inc., today announced the execution of a marketing, sales and distribution agreement for Interleukin Genetics' proprietary PST(R) Genetic Test. The PST(R) Genetic Test provides a means of assessing an individual's genetic risk for periodontal disease, the most common cause of tooth loss. Under the terms of the agreement, OralDNA will receive a non-exclusive license from Interleukin Genetics to market, sell and distribute Interleukin Genetics' proprietary PST(R) Genetic Test to dental practices within the United States. OralDNA will pay Interleukin Genetics a set fee per test for all tests sold by OralDNA and is responsible for all costs it incurs for marketing such tests. Patients will be asked in the informed consent if they would like to receive additional testing services, other than the PST(R) Genetic Test, provided by Interleukin Genetics.

Lewis H. Bender, Chief Executive Officer of Interleukin Genetics, commented, "We are pleased to have entered into this license agreement for OralDNA to market our PST(R) Genetic Test as a determinant of risk for periodontal disease. We believe that this relationship will allow our sales of this important product to grow with a sales force that specifically targets dental practices. In addition, we expect that this agreement with OralDNA Labs will enable our core strategy of growth through partnerships and should allow Interleukin Genetics to build a customer base to provide additional test services."

Brian C. Carr, Chief Executive Offic
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results
2. Interleukin Genetics to Present at 2008 BIO International Convention
3. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
4. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
5. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
6. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
7. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
8. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
9. Interleukin Genetics Retains Top Life Science Communications Firms
10. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
11. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... York (PRWEB) July 25, 2014 According ... Research, "Biological Drugs Market - Global Industry Analysis, Size, ... global biological drugs market is estimated at USD 161,056.5 ... a CAGR of 10.1% from 2014 to 2020, to ... 2020. , The biological drugs market is witnessing a ...
(Date:7/25/2014)... The Conferee Networking committee is pleased ... Networking. These two-hour sessions provide a unique networking opportunity ... problems, discuss new techniques, or brainstorm new ideas in ... topic for consideration is August 31, 2014, and instructions ... Networking committee will review the topics, and status notifications ...
(Date:7/25/2014)... 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... today announced financial results for the period ended June ... , Reported cash and cash equivalents totaling $37.4 ... December 31, 2013.  , Reported a net loss ...
(Date:7/25/2014)... At the request of the AMA, the Federal ... the public comment period (Docket No. FAA-2014-0396) for FAA’s ... by Congress as part of the FAA Modernization and ... new deadline for comments as September 23, 2014. , ... in the Federal Register on July 25, 2014, the ...
Breaking Biology Technology:Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6FAA Grants Comment Extension at the Request of AMA 2
... during the first quarter of 2005 amid poor overall stock ... at the larger cap life science companies. Note that these ... You may have noticed headlines at the end of last ... Cox-2 inhibitor (Bextra) off the market. , ,This stronger-than-expected action ...
badgernet badgernet badgernet ,badgernet badgernet badgernet ,badgernet badgernet badgernet ,badgernet badgernet badgernet badgernet badgernet...
... voted late Tuesday night to amend a bill granting ... newly created human embryonic stem cells would be denied. ... firms that do any research involving the destruction of ... cells from them after August 9, 2001. It ...
Cached Biology Technology:Midwest large-cap life-science sector is solid in first quarter 2Bill would deny tax credits to firms creating stem-cell cultures 2
(Date:7/25/2014)... CORAL SPRINGS, Florida , July 25, 2014 /PRNewswire/ ... influential as more consumers are turning to digital technology ... NXT-ID, Inc. (OTCBB: NXTD), Google Inc. (NASDAQ: ... Visa Inc. (NYSE: V ), Apple Inc. ... FTNT) NXT-ID, Inc., (OTCQB: NXTD) a biometric ...
(Date:7/24/2014)... Scientists at The New York Stem Cell ... to creating a viable cell replacement therapy for ... , For the first time, NYSCF scientists generated ... samples of patients with primary progressive multiple sclerosis ... induce these stem cells into becoming oligodendrocytes, the ...
(Date:7/24/2014)... Angeles, where electric cars ply silent freeways, solar panels ... beneath the earth, from howling winds and from the ... that it is technically and economically feasible to convert ... renewable energy. Published in Energy , the plan ... energy supply in California that could create tens of ...
Breaking Biology News(10 mins):Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4
... -- Neither births nor deaths stop the flocking of organisms. ... of the University of Oregon. The notion, he says, has ... therapies. Picture any scenario in which self-propelled organisms -- ... even tiny plastic rods on a vibrating table -- move ...
... Nanoparticles have many useful applications, but also raise ... shows that plastic nanoparticles are transported through the aquatic ... full report is published Feb. 22 in the open ... to nanoparticles slowed their feeding behavior, and also affected ...
... at Buffalo engineers have developed a one-step, low-cost method ... from a single perspective, the polymer is rainbow-colored, reflecting ... filter for light, this material could form the basis ... color" of objects examined. An image of the material ...
Cached Biology News:New theory shows that neither birth nor death stops a flock 2New theory shows that neither birth nor death stops a flock 3A rainbow for the palm of your hand 2
... Plasma Immunodepletion Kit specifically removes 20 of ... or serum in preparation for further proteomics ... the plasma proteome whether you use one- ... or go straight to mass spectrometry. This ...
... a direct antibiotic-based selection ... Recombinant selection depends solely ... the need for costly ... and inexpensive process provides ...
... can perform many sophisticated DNA analysis and protein ... than just another sequence analysis product. Imagine having ... analyses to be performed each time you have ... sheets which specify exactly how your output will ...
... is the first fully automated proteomics workcell. ... operations with complete data tracking. It automates ... picking through final protein expression and measurement. ... delivering a plate to any of its ...
Biology Products: